Company: CSTL
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001447362-25-000097
Chunk: 0

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-08-04
Form: 10-Q
Item: Item 1
Chunk 0
---
Item 1. Financial Statements.

CASTLE BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

June 30, 2025December 31, 2024ASSETS(unaudited)Current Assets  Cash and cash equivalents$82,233 $119,709 Marketable investment securities193,697 173,421 Accounts receivable, net52,311 51,218 Inventory8,366 8,135 Prepaid expenses and other current assets12,061 7,671 Total current assets348,668 360,154 Long-term accounts receivable, net1,132 918 Property and equipment, net74,060 51,122 Operating lease assets15,503 11,584 Goodwill and other intangible assets, net104,125 106,229 Other assets – long-term1,241 1,228 Total assets$544,729 $531,235 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent LiabilitiesAccounts payable$13,181 $6,901 Accrued compensation24,973 32,555 Contingent consideration1,000 — Operating lease liabilities1,571 1,665 Current portion of long-term debt1,944 278 Other accrued and current liabilities8,221 7,993 Total current liabilities50,890 49,392 Long-term debt8,096 9,745 Noncurrent portion of contingent consideration1,500 — Noncurrent operating lease liabilities25,377 14,345 Noncurrent finance lease liabilities364 311 Deferred tax liability3,126 1,607 Total liabilities89,353 75,400 Commitments and Contingencies (Note 12)Stockholders’ EquityPreferred stock, $0.001 par value per share; 10,000,000 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued and outstanding as of June 30, 2025 and December 31, 2024— — Common stock, $0.001 par value per share; 200,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 28,981,151 and 28,483,195 shares issued and outstanding as of June